Skip to main content
TipRanks
Go Ultimate75% OFF

Marc Steven Hanover Insider Profile

4 Followers

Marc Steven Hanover, former CEO, Director at Oncternal Therapeutics, holds 172.05K shares in Oncternal Therapeutics (Ticker: ONCT). Most recently, Marc Steven Hanover Sold 7,309 shares of Oncternal Therapeutics on Jan 09, 2018 for an estimated value of $82.85K.

Marc Steven Hanover's Trading History

ONCT
Oncternal Therapeutics
Jan 09, 2018―Informative Sell82.85K$90.50K
ONCT
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 09, 2018Informative Sell$82.85K7,309$11.33+90.80%
Jan 03, 2018Uninformative Sell$81.31K6,397$12.71―
Oct 17, 2016Uninformative Buy$100.00K123,456$0.81―
Jan 26, 2016Informative Buy$2.60K4,000$0.65-8.70%
Jan 25, 2016Informative Buy$7.94K12,813$0.62-20.30%

You May Also Like

Marc Steven Hanover insider profile FAQ

What is the percentage of profitable transactions made by Marc Steven Hanover?
The percentage of profitable transactions made by Marc Steven Hanover is 45%.
What is the average return per transaction made by Marc Steven Hanover?
The average return per transaction made by Marc Steven Hanover is 8.10%.
What stocks does Marc Steven Hanover hold?
Marc Steven Hanover holds: ONCT stocks.
What was Marc Steven Hanover’s latest transaction?
Marc Steven Hanover’s latest transaction was an Informative Sell of $82.85K.
What was Marc Steven Hanover's most profitable transaction?
Marc Steven Hanover’s most profitable transaction was an Informative Sell of ONCT stock on January 9, 2018. The return on the trade was 90.80%.
What is Marc Steven Hanover's role in Oncternal Therapeutics?
Marc Steven Hanover's role in Oncternal Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.